Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



BAUM MARK L Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 4 BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns: Bought 5,800 shares @ $17.05, valued at $98.9k
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2023 4 BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns: Paid exercise price by delivering 117,633 shares @ $20.97, valued at $2.5M
Exercised 180,000 options to buy @ $8.99, valued at $1.6M
Granted 762,300 restricted stock units @ $0
01/03/2023 4 BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns: Paid exercise price by delivering 35,179 shares @ $14.76, valued at $519.2k
Exercised 88,000 options to buy @ $0
12/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/21/2022 4 BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns: Paid exercise price by delivering 71,406 shares @ $8.33, valued at $594.8k
Exercised 125,000 options to buy @ $2.4, valued at $300k
07/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2020 4 BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns: Disposed/sold 600,000 options to buy @ $7.87, valued at $4.7M
Granted 600,000 options to buy @ $7.87, valued at $4.7M
03/16/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/25/2019 4 BAUM MARK L (CEO) has filed a Form 4 on HARROW HEALTH, INC.
Txns: Exercised (in-or-at-the-money) 156,000 shares @ $1.79, valued at $279.2k
Exercised (in-or-at-the-money) 156,000 options to buy @ $1.79, valued at $279.2k
03/08/2019 4 BAUM MARK L (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.
Txns: Granted 12,500 options to buy @ $7.31, valued at $91.4k
02/21/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2018 4 BAUM MARK L (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.
Txns: Bought 10,000 shares @ $6, valued at $60k
01/04/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/20/2017 4 BAUM MARK L (Director) has filed a Form 4 on Ideal Power Inc.
12/21/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
04/26/2016 4 BAUM MARK L (CEO) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.
Txns: Granted 1,050,000 options to buy @ $0
Disposed/sold 1,050,000 options to buy @ $0
04/05/2016 4 BAUM MARK L (CEO) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.
Txns: Granted 180,000 options to buy @ $3.95, valued at $711k
01/06/2016 4 BAUM MARK L (Director) has filed a Form 4 on Ideal Power Inc.
Txns: Granted 12,834 options to buy @ $7.32, valued at $93.9k
Granted 12,646 options to buy @ $7.94, valued at $100.4k
11/17/2015 4 BAUM MARK L (Director) has filed a Form 4 on Ideal Power Inc.
Txns: Sold 29,063 shares @ $7.535, valued at $219k
08/05/2015 4 BAUM MARK L (CEO) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.
Txns: Granted 600,000 options to buy @ $7.87, valued at $4.7M
02/11/2014 4 BAUM MARK L (CEO) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.
Txns: Granted 15,400 options to buy @ $7.71, valued at $118.7k
01/07/2014 4 BAUM MARK L (Director) has filed a Form 4 on Ideal Power Inc.
Txns: Granted 10,861 shares @ $5, valued at $54.3k
Granted 12,742 options to buy @ $5.49, valued at $70k
12/02/2013 4 BAUM MARK L (Director) has filed a Form 4 on Ideal Power Inc.
Txns: Acquired 29,063 shares @ $3.48, valued at $101.1k
Converted 1 convertible notes @ $3.48, valued at $3.5
05/06/2013 4 BAUM MARK L (CEO) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.
Txns: Granted 1,050,000 shares @ $0
Granted 200,000 shares @ $0
Granted 180,000 options to buy @ $8.99, valued at $1.6M
07/20/2012 4 BAUM MARK L (CEO) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.
Txns: Converted 7,498,500 shares @ $0
Acquired 846,927 shares @ $0
Granted 800,000 shares @ $0
Converted 10 convertible preferred @ $0.0013, valued at $0
10/22/2010 4 BAUM MARK L (CEO) has filed a Form 4 on Shrink Nanotechnologies, Inc.
Txns: Sold 100,000 shares @ $0.14, valued at $14k
Sold 100,000 shares @ $0.151, valued at $15.1k
Sold 424,983 shares @ $0.118, valued at $50.1k
10/18/2010 4 BAUM MARK L (CEO) has filed a Form 4 on Shrink Nanotechnologies, Inc.
Txns: Sold 300,000 shares @ $0.143, valued at $42.9k
Sold 270,000 shares @ $0.0143, valued at $3.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy